Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Reset all filters
01 2Athena Pharmaceutiques
02 7Cohance Lifesciences
03 12Orion Corporation
04 26Granules India Limited
05 32care4
06 7Actavis Inc
07 13Ajanta Pharma Limited
08 7Alkem Laboratories
09 7Alvogen
10 6Amneal Pharmaceuticals
11 20Apotex Inc
12 7Aristo Pharma GmbH
13 9Assia Chemical Industries Ltd
14 1Azurity Pharma
15 8Ebb Medical
16 7Elite Laboratories
17 1FrostPharma AB
18 1Frostpharma Ab
19 7Hikma Pharmaceuticals
20 7JAMP PHARMA
21 7Lannett Company, Inc.
22 6MSN Laboratories
23 13Mallinckrodt Pharmaceuticals
24 6Medartuum
25 10ORIFARM GROUP AS
26 7PRO DOC LIMITEE
27 7Prinston
28 7RHODES PHARMACEUTICALS LP
29 6SHIRE PLC
30 6STADA Arzneimittel
31 32Sandoz B2B
32 6Spirig Healthcare
33 13Sun Pharmaceutical Industries Limited
34 68Takeda Pharmaceutical
35 6Takeda Pharmaceuticals Australia Pty. Ltd.
36 6Taro Pharmaceutical Industries
37 25Teva Pharmaceutical Industries
38 7Viatris
Reset all filters
01 3CAP
02 42CAPSULE
03 118CAPSULE;ORAL
04 77Capsule
05 6Capsule, hard
06 30Hard Capsule
07 7Immediate Release Capsule
08 6Immediate Release Chewable Tablet
09 35Kapsel, hard
10 1Mixture, solution
11 2Oral Solution
12 2Oral-Dispersible Tablet
13 1SOLUTION;ORAL
14 18TABLET (CHEWABLE)
15 42TABLET, CHEWABLE;ORAL
16 3capsule
17 3Blank
Reset all filters
01 12Allowed
02 49Approved
03 16Authorized
04 60CONTROLLED DRUGS (CDSA I)
05 3Cancelled
06 22Deregistered
07 3Originator
08 161RX
09 70Blank
Reset all filters
01 7APO-LISDEXAMFETAMINE CAPSULES
02 6APO-LISDEXAMFETAMINE CHEWABLE TABLETS
03 1ARYNTA
04 6Adixel
05 11Aduvanz
06 12Balidax
07 12Dexhility
08 44Elvanse
09 3Elvanse Adultos
10 14Elvanse Vuxen
11 7JAMP LISDEXAMFETAMINE
12 147LISDEXAMFETAMINE DIMESYLATE
13 1Lisarol
14 6Lisdexamfetamin Orion Pharma
15 2Lisdexamfetamin Spirig HC
16 2Lisdexamfetamine
17 13Lisdexamfetamine Dimesylate
18 6Lisdexamfetamine Orion
19 4Lisdexamfetamine Spirig HC
20 3Lisdexanfetamina Teva
21 7Manollia
22 3Oferlanz
23 3Offerlanz
24 7PRO-LISDEXAMFETAMINE
25 7SANDOZ LISDEXAMFETAMINE CAPSULES
26 1Silaroza
27 6TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
28 7TEVA-LISDEXAMFETAMINE
29 26VYVANSE
30 6Volidax
31 6Vyvanse
32 1Vyvanse 30
33 1Vyvanse 50
34 1Vyvanse 70
35 7Blank
Reset all filters
01 6Australia
02 60Canada
03 2France
04 20India
05 42Norway
06 3South Africa
07 19Spain
08 71Sweden
09 12Switzerland
10 161USA
Regulatory Info :
Registration Country : France
Brand Name : Lisdexamfetamine
Dosage Form : Oral-Dispersible Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 20mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000140
Regulatory Info : Approved
Registration Country : Sweden
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : France
Brand Name : Lisdexamfetamine
Dosage Form : Oral-Dispersible Tablet
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 30mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000157
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 40mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000164
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 50mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000171
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 60mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000188
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 70mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000195
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 20mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000115
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 30mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000122
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 40mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000139
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 50mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000146
Regulatory Info : Approved
Registration Country : Sweden